In a city where most residents are within a short distance of world class academic medical centers, and in a state that makes health insurance available to all, why is there such a such a disparity in life expectancy among the residents of three Boston neighborhoods?
Blog
Can a light-based treatment called photobiomodulation help to treat degenerative brain diseases?
The REVIVE clinical trial team is seeking feedback from the public on their study testing the use of RESQFOAM in severely injured trauma patients.
Harald Jueppner, MD Advances in medical care often take a long and winding path from a new laboratory discovery to the patient bedside. So it is particularly gratifying as a physician-scientist when you have the opportunity to offer your patients a new treatment that came about in part from research in your own laboratory. ForRead more
Clostridium perfringens is a common foodborne illness that causes nearly 1 million infections each year. The bacterium has many environmental sources, but is typically found on raw meat and poultry.
Yangyundou Wang, PhD In recognition of National Postdoc Appreciation Week, we’re profiling some of the postdoctoral researchers who make invaluable contributions to scientific research at Massachusetts General Hospital every day. Yangyundou Wang, PhD, is a postdoctoral fellow working in the Vakoc Lab at the Wellman Center for Photomedicine. My work at Mass General is veryRead more
Michael VanElzakker, PhD, is a neuroscientist at Mass General who is using brain scans to learn more about chronic fatigue syndrome.
Scientific research is complex and often not straightforward. Thus, one needs to be smart, well-organized and hardworking to be successful. So, work hard, learn new things each minute, try to become better each day, and you will be acknowledged.
Mass General clinician-researcher Jennifer Temel, MD, a Hostetter MGH Research Scholar, is studying the effects of palliative care on quality of life for patients with serious illnesses.
A spotlight on the Massachusetts General Hospital researchers who were named 2018 KL2/CMerit Awardees by Harvard Catalyst.
